Abstract:Background: It was well studied that HER2/ErbB2/p185 overexpression in human malignant cancers correlates with poor prognosis and chemo-resistance. Meanwhile, Genistein (4,5,7trihydroxyisoflavone), a major isoflavone component of soybeans and other leguminous plants, has been shown to exhibit a potent anti-proliferative effect on some sex hormone dependent cancers. Objective: The effects of genistein on the proliferation of human HER2-overexpressing breast and ovarian cancer cell lines were investigated, and the action mechanism was explored. Methods: Western blotting, fluorescence-activated cell sorting (FACS) and immunofluorescence methods, cell proliferation assay kit from Promega and cell apoptosis assay kit from Biolegend were used. The doseor time-response relationship of genistein were observed on the HER2negative breast cancer cell line MCF-7 or HER2-positive breast cancer cell lines BT-474 and MCF-7/Her2 derived from MCF-7, and ovarian cancer cell line SKOV-3. Results: The addition of genistein ranged from 1-10g/ml in the medium for 48 hours had a marked inhibition on the proliferation of HER2-positive cancer cell lines MCF-7/Her2, BT-474 and SKOV-3, compared with tamoxifen and DMSO control (P<0.01), and a dose-dependent response was presented. However, genistein exerted a weak inhibitive effect on HER2-negative breast cancer cell line MCF-7. There was a significant apoptosis or necrosis effect of BT-474 cells induced by 10 g/ml genistein for 12-48 hours in comparison with DMSO control (P<0.01), and a time-dependent response relationship. Moreover, genistein could down-regulate HER2 receptor expression and AKT kinase activity by using immunofluorescence and western blotting methods. Functional Foods in Health and Disease 2013; 3(7):291-299 Page 292 of 299 Conclusion: Our findings demonstrated that genistein could effectively inhibit the proliferation of HER2-positive cancer cell lines, which should be through down-regulating HER2 receptor and downstream signaling.

Bcl-2 Overexpression Sensitizes MCF-7 Cells to Genistein by Multiple Mechanisms

Effect of Proliferation, Cell Cycle, and Bcl-2s of MCF-7 Cells by Resveratrol

Genistein induces enhanced growth promotion in ER-positive/erbB-2-overexpressing breast cancers by ER-erbB-2 cross talk and p27/kip1 downregulation.

Genistein Induces Apoptosis in Acute Myeloid Leukemia Cells and Affects Proteasome Pathway by Proteomic Analysis

Genistein Inhibits Brca1 Mutant Tumor Growth Through Activation of DNA Damage Checkpoints, Cell Cycle Arrest, and Mitotic Catastrophe

Inhibitory actions of genistein in human breast cancer (MCF-7) cells

Apoptosis induced by genistein in esophageal cancer EC-109 cells and its relation to Bcl-2 and Bax

Genistein Inhibits the Proliferation of Human HER2-positive Cancer Cells by Downregulating HER2 Receptor

Effect of genistein on growth of human breast cancer cell MCF-7

[Genistein Exerts Multiple Suppressive Effects on Human Breast Carcinoma Cells].

Genistein inhibits both constitutive and EGF-stimulated invasion in ER-negative human breast carcinoma cell lines

Genistein Inhibits Proliferation Similarly in Estrogen Receptor-Positive and Negative Human Breast Carcinoma Cell Lines Characterized by P21WAF1/CIP1 Induction, G2/M Arrest, and Apoptosis.

Effects of Genistein on Cell Cycle and Apoptosis of Two Murine Melanoma Cell Lines

Caspase-3 Status Is A Determinant Of The Differential Responses To Genistein Between Mda-Mb-231 And Mcf-7 Breast Cancer Cells

Potential therapeutic mechanism of genistein in breast cancer involves inhibition of cell cycle regulation

Apoptosis of Human Primary Gastric Carcinoma Cells Induced by Genistein

Genistein, A Dietary Isoflavone, Down-Regulates the Mdm2 Oncogene at Both Transcriptional and Posttranslational Levels

Metabolic reprogramming and synergistic cytotoxicity of genistein and chemotherapy in human breast cancer cells

Genistein inhibited proliferation and induced apoptosis in acute lymphoblastic leukemia, lymphoma and multiple myeloma cells in vitro.

Sensitizing non-small cell lung cancer to BCL-xL-targeted apoptosis

Genistein upregulates cyclin D1 and CDK4 expression and promotes the proliferation of ovarian cancer OVCAR-5 cells